MedTrace Logo

Central Venous Catheter-related Complications in Patients Under Anticancer Treatment

NCT05455866 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-07-13

No results posted yet for this study

Summary

Oncology and hemotology patients under anticancer treatments are exposed to increased risks of central venous catheter-related complications due to the underlying cancer and its treament.

This prospective observational monocentric french study aims at describing the incidence of such complications, their morbimortality, and analyzing some risk factors in order to contribute to propose some strategies to reduce these complications' rate and consequences

Conditions

  • Central Venous Catheter Thrombosis
  • Central Venous Catheter Related Bloodstream Infection
  • Solid Tumor
  • Hematologic Malignancy

Interventions

DEVICE

central venous catheter

collection and descriptionof central venous catheter-related complications

Sponsors & Collaborators

  • Centre Hospitalier Alpes Leman

    lead OTHER

Principal Investigators

  • Florence OBERKAMPF · Centre Hospitalier Alpes Leman

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-11
Primary Completion
2023-01-31
Completion
2023-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05455866 on ClinicalTrials.gov